2016 annual financial data
UroGen Pharma 2016 Operating margin
UroGen Pharma 2016 operating margin with verified reported values.
Direct answer
Operating margin was 4.55%.
Operating income was 798,000 USD and net income was -1,941,000 USD.
Operating cash flow was 4,189,000 USD.
Get free UroGen Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 17,530,000 USD
- Operating income
- 798,000 USD
- Net income
- -1,941,000 USD
- Operating cash flow
- 4,189,000 USD